Optiver Holding
RYTM icon

Optiver Holding’s Rhythm Pharmaceuticals RYTM Stock Holding History

Optiver Holding’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.4K Buy
220
+170
+340% +$15.4K ﹤0.01% 1436
2026
Q1 		$4.35K Sell
50
-42
-46% -$4.08K ﹤0.01% 1478
2025
Q4 		$9.85K Sell
92
-273
-75% -$29K ﹤0.01% 1147
2025
Q3 		$36.9K Buy
365
+144
+65% +$13.4K ﹤0.01% 836
2025
Q2 		$14K Buy
221
+66
+43% +$4.04K ﹤0.01% 920
2025
Q1 		$8.21K Buy
+155
New +$8.6K ﹤0.01% 953

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Optiver Holding's RYTM Position: Q2 2026 in Review

Optiver Holding increased its Rhythm Pharmaceuticals (RYTM) stake by 340% in Q2 2026, buying an estimated $15.4K and bringing the position to 220 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Optiver Holding first reported a position in RYTM in Q1 2025 and has held it in 6 quarters since. The position peaked at $36.9K in Q3 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Optiver Holding held 220 shares of Rhythm Pharmaceuticals worth $24.4K as of Q2 2026.
  • Optiver Holding bought 170 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $15.4K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1436 holding.
  • Optiver Holding first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Optiver Holding's Rhythm Pharmaceuticals position peaked at $36.9K in Q3 2025.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.